Literature DB >> 3469152

Comparative activity of ofloxacin and seven other antimicrobials against urea-splitting microorganisms.

A Torres, R Fernández-Roblas, B Méndez, F Soriano.   

Abstract

Urinary tract infections caused by urea-splitting bacteria are severe clinical conditions and very difficult to treat due to their association with calculi, and because such bacteria form ammonium hydroxide raising the urinary pH and thereby creating an unfavourable condition for the action of most antimicrobials. We tested ofloxacin, norfloxacin, nalidixic acid, amoxicillin, amoxicillin-clavulanic acid, gentamicin, co-trimoxazole and nitrofurantoin against 143 gram-negative and 99 gram-positive bacteria, all urea-splitting, isolated from patients with urinary tract infections. All drugs were tested using media at two different pHs (pH 7.4 and PH 8.5) and two inoculum sizes (10(4) and 10(6) cfu). Although ofloxacin and norfloxacin had a similar spectrum of activity, ofloxacin had somewhat greater intrinsic activity against gram-positive organisms. MICs of ofloxacin for 90% of Proteus mirabilis, indole-positive Proteus spp., Klebsiella pneumoniae, Staphylococcus aureus, coagulase-negative staphylococci and the Corynebacterium group D2 were greater than or equal to 4 mg/l. The activity of the other drugs varied, but there were many strains resistant to these antimicrobials. The pH and inoculum size did not significantly affect the activity of ofloxacin so that this drug should be useful for the treatment of urinary tract infections caused by the commonest urea-splitting bacteria involved in such infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3469152     DOI: 10.1007/BF01661279

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Rapid identification of antibiotic-resistant corynebacteria with the API 20S system.

Authors:  M C Kelly; I D Smith; R J Anstey; J H Thornley; R P Rennie
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

2.  In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

Authors:  D S Reeves; M J Bywater; H A Holt; L O White
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

3.  The in vitro and in vivo activity of ciprofloxacin.

Authors:  H J Zeiler; K Grohe
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

4.  Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.

Authors:  G Seibert; M Limbert; N Klesel
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

5.  Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.

Authors:  D Greenwood; M Osman; J Goodwin; W A Cowlishaw; R Slack
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

6.  In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.

Authors:  R Wise; J M Andrews; G Danks
Journal:  J Antimicrob Chemother       Date:  1984-03       Impact factor: 5.790

7.  Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.

Authors:  C H Teoh-Chan; A Cowlishaw; A Eley; G Slater; D Greenwood
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

8.  Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms.

Authors:  F Soriano; C Ponte; M Santamaria; J M Aguado; I Wilhelmi; R Vela; L C Delatte
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

9.  The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity.

Authors:  D S Reeves; M J Bywater; H A Holt
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

  9 in total
  2 in total

Review 1.  Ofloxacin clinical pharmacokinetics.

Authors:  K C Lamp; E M Bailey; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

2.  Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group.

Authors:  A Gwon
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.